These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 8490203)
1. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines. Kido Y; Khokhar AR; Siddik ZH Anticancer Drugs; 1993 Apr; 4(2):251-8. PubMed ID: 8490203 [TBL] [Abstract][Full Text] [Related]
2. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands. Kido Y; Khokhar AR; al-Baker S; Siddik ZH Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629 [TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity, cellular accumulation and DNA binding of oxaliplatin isomers. Pendyala L; Kidani Y; Perez R; Wilkes J; Bernacki RJ; Creaven PJ Cancer Lett; 1995 Nov; 97(2):177-84. PubMed ID: 7497460 [TBL] [Abstract][Full Text] [Related]
4. Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines. Yoshida M; Khokhar AR; Siddik ZH Cancer Res; 1994 Jul; 54(13):3468-73. PubMed ID: 8012968 [TBL] [Abstract][Full Text] [Related]
5. Role of carrier ligand in platinum resistance of human carcinoma cell lines. Schmidt W; Chaney SG Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361 [TBL] [Abstract][Full Text] [Related]
6. Role of carrier ligand in platinum resistance in L1210 cells. Gibbons GR; Page JD; Mauldin SK; Husain I; Chaney SG Cancer Res; 1990 Oct; 50(20):6497-501. PubMed ID: 2208108 [TBL] [Abstract][Full Text] [Related]
7. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells. Gibbons GR; Kaufmann WK; Chaney SG Carcinogenesis; 1991 Dec; 12(12):2253-7. PubMed ID: 1747924 [TBL] [Abstract][Full Text] [Related]
8. Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR Anticancer Drug Des; 1994 Apr; 9(2):139-51. PubMed ID: 8166929 [TBL] [Abstract][Full Text] [Related]
9. Glutathione-mediated modulation of tetraplatin activity against sensitive and resistant tumor cells. Kido Y; Khokhar AR; Siddik ZH Biochem Pharmacol; 1994 Apr; 47(9):1635-42. PubMed ID: 8185678 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II). Viale M; Cafaggi S; Parodi B; Esposito M Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917 [TBL] [Abstract][Full Text] [Related]
11. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation. Jennerwein MM; Eastman A; Khokhar AR Mutat Res; 1991 Jan; 254(1):89-96. PubMed ID: 1986276 [TBL] [Abstract][Full Text] [Related]
12. Ascorbato(1,2-diaminocyclohexane):platinum(II) complexes, a new series of water-soluble antitumor drugs. Hacker MP; Khokhar AR; Brown DB; McCormack JJ; Krakoff IH Cancer Res; 1985 Oct; 45(10):4748-53. PubMed ID: 4040806 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of novel ammine/amine platinum (IV) dicarboxylates in L1210 murine leukaemia cells sensitive and resistant to cisplatin, tetraplatin or carboplatin. Orr RM; O'Neill CF; Nicolson MC; Barnard CF; Murrer BA; Giandomenico CM; Vollano JF; Harrap KR Br J Cancer; 1994 Sep; 70(3):415-20. PubMed ID: 8080724 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of isomeric 1,2-diaminocyclohexane platinum(IV) complexes. Siddik ZH; al-Baker S; Thai G; Khokhar AR J Cancer Res Clin Oncol; 1994; 120(7):409-14. PubMed ID: 8188734 [TBL] [Abstract][Full Text] [Related]
15. Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines. Yoshida M; Khokhar AR; Siddik ZH Anticancer Drug Des; 1994 Oct; 9(5):425-34. PubMed ID: 7945726 [TBL] [Abstract][Full Text] [Related]
16. Differential antitumor activity and toxicity of isomeric 1,2-diaminocyclohexane platinum (II) complexes. Siddik ZH; al-Baker S; Burditt TL; Khokhar AR J Cancer Res Clin Oncol; 1993; 120(1-2):12-6. PubMed ID: 8270602 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, structural characterization, and antitumor properties of a novel class of large-ring platinum(II) chelate complexes incorporating the cis-1,4-diaminocyclohexane ligand in a unique locked boat conformation. Hoeschele JD; Showalter HD; Kraker AJ; Elliott WL; Roberts BJ; Kampf JW J Med Chem; 1994 Aug; 37(17):2630-6. PubMed ID: 8064793 [TBL] [Abstract][Full Text] [Related]
18. Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes. Khokhar AR; al-Baker S; Shamsuddin S; Siddik ZH J Med Chem; 1997 Jan; 40(1):112-6. PubMed ID: 9016335 [TBL] [Abstract][Full Text] [Related]
19. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo. Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375 [TBL] [Abstract][Full Text] [Related]
20. Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours. Goddard PM; Orr RM; Valenti MR; Barnard CF; Murrer BA; Kelland LR; Harrap KR Anticancer Res; 1996; 16(1):33-8. PubMed ID: 8615631 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]